SynthesisInternational journal of obesity (2005)2026
Regular collagen peptide administration exerts anti-obesity effects in high-caloric diet-fed rodents-a systematic review with meta-analysis of animal trials.
Synthesis in International journal of obesity (2005), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCost-effective and easy-to-implement nutritional approaches to overcoming obesity and accompanying diseases remain of considerable therapeutic interest. Collagen peptides (CP) have previously demonstrated potential to alleviate obesity and related symptoms during high-fat/ high-caloric diets. Therefore, a systematic review and meta-analysis have been conducted to pool the evidence from the last decades.
methodsA systematic literature search was conducted in accordance with the PRISMA statement in PubMed, Scopus, CINAHL, MEDLINE and ScienceDirect in March 2024. Risk of bias was assessed using the SYRCLE tool for animal studies. A random-effects model with standardized mean differences (SMD) calculated overall effect sizes. Preclinical controlled trials as well as randomized controlled trials were eligible if rodents received a high-fat or high-caloric diet, were genetically not modified and administered CPs compared to a placebo for at least 3 weeks.
resultsTwenty-one and nineteen (n = 339) studies were included in the systematic review and meta-analysis, respectively. A several-week CP supplementation led to significant decreases in body mass (p < 0.01; SMD = -1.87), food intake (p = 0.01; SMD = -1.43), glucose metabolism (p < 0.02; SMD = -2.21), adipose tissue & organ content (p < 0.01; SMD = -1.26), LDL (p < 0.01; SMD = -2.02), triacylglycerol (p < 0.01; SMD = -2.16) and leptin (p = 0.01; SMD = -1.33). Significant increases were observed in HDL (p = 0.04; SMD = 1.14) and adiponectin (p < 0.01; SMD = 1.04). A moderate to high risk of bias, combined with a very low certainty of evidence for each parameter, was apparent.
conclusionCP administration in rodents with obesity for at least 3 weeks demonstrated significant anti-obesity effects by positively influencing body mass, food intake, glucose metabolism, lipid markers, adipose tissue and adipokines. However, CP's anti-obesity effects in humans remain largely unexplored, necessitating further research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.